• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Sotatercept (Winrevair) Approved
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Getting The Most From Your PAH Therapy

August 26, 2015 By Dr. Jeremy Feldman

PAH medications

We would like to introduce a new series on PulmonaryHypertensionRN.com.  This series will include periodic articles focusing on a specific therapy and how to benefit maximally and minimize side effects. Letairis (Ambrisentan) Efficacy in Pulmonary Hypertension This medicine was first approved in 2007 based on 2 studies that both showed improvement in exercise capacity and … [Read more...]

Update on Clinical Trials for PAH

August 17, 2015 By Dr. Jeremy Feldman

PAH research

The past decade has been a very exciting time to treat patients with Pulmonary Arterial Hypertension (PAH).  New treatments have been approved that have dramatically improved outcomes for PAH patients. Compared to 20 years ago when we had a single medication to treat PAH we now have 13 treatments.  Once a disease treated in a small number of university centers, PAH is now … [Read more...]

Exercise and Pulmonary Arterial Hypertension

July 19, 2015 By Dr. Jeremy Feldman

Caregiver excercise

A common question that I am asked by patients is how much activity can they safely perform.  What type of exercise is safe?  Should patients exercise?  In the past, patients with heart and lung disease were advised to avoid exercise.  We now know much better!  Not only does exercise improve your stamina, it also improves you muscle strength and sense of well-being.  During … [Read more...]

Buyer Beware: Stem Cells In PAH

March 6, 2015 By Dr. Jeremy Feldman

researching stem cells to treat PAH

Have you seen the new ads promising to cure your ________ (you fill in the blank with whatever disease you have) with stem cell therapy?  Did you read the small print? Lately my patients have been increasingly asking me about stem cell therapy for PAH.  Patients are bringing in pretty advertisements from companies that are making grand promises. Too good to be true? … [Read more...]

New Year: New Insurance Authorizations for PAH Medications

December 16, 2014 By Dr. Jeremy Feldman

PAH New Year

As we bring 2014 to an end and ring in the start of 2015 take a quick break from family, friends, and festivities to double check the authorizations of your PAH medications. … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

PAH resolutions

3 New Year’s Resolutions for PAH Patients

By Dr. Jeremy Feldman

The streamers have fallen and the ball has dropped. 2017 is off to a fast start. The beginning of a new year is a

News about PAH

Help Arrives for Some PAH Patients Who Can’t Afford Their Medication

By Dr. Jeremy Feldman

Thousands of Pulmonary Arterial Hypertension patients across America are now experiencing a crisis.  They previously

good news in pah

 

Disclaimer

Recent Blog Posts

  • Making Order from Chaos October 26, 2025
  • Sotatercept: ZENITH and HYPERION Trials June 22, 2025
  • In Memoriam:  Greg Ahearn, MD June 16, 2024

Categories

Archives